Antisense Bcl2 oligonucleotide in cisplatin‐resistant bladder cancer cell lines

Abstract

Up-regulation of Bcl2 protein expression might be one of the mechanisms of cisplatin resistance in bladder cancer cells, and antisense Bcl2 oligonucleotide may be helpful in chemotherapy for bladder cancer by reversing cisplatin resistance.